A Novel Mutation Causing 17-β-Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Omani Child: First Case Report and Review of Literature
- PMID: 25960839
- PMCID: PMC4412451
- DOI: 10.5001/omj.2015.27
A Novel Mutation Causing 17-β-Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Omani Child: First Case Report and Review of Literature
Abstract
This is the first case report in Oman and the Gulf region of a 17-β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency with a novel mutation in the HSD17B3 gene that has not been previously described in the medical literature. An Omani child was diagnosed with 17-β-HSD3 deficiency and was followed up for 11 years at the Pediatric Endocrinology Clinic, Royal Hospital, Oman. He presented at the age of six weeks with ambiguous genitalia, stretched penile and bilateral undescended testes. Ultrasound showed no evidence of any uterine or ovarian structures with oval shaped solid structures in both inguinal regions that were confirmed by histology to be testicular tissues with immature seminiferous tubules only. The diagnosis was made by demonstrating low serum testosterone and high androstenedione, estrone, and androstenedione:testosterone ratio. Karyotyping confirmed 46,XY and the infant was raised as male. Testosterone injections (25mg once monthly) were given at two and six months and then three months before his surgeries at five and seven years of age when he underwent multiple operations for orchidopexy and hypospadias correction. At the age of 10 years he developed bilateral gynecomastia (stage 4). Laboratory investigations showed raised follicle-stimulating hormone, luteinizing hormone, androstenedione, and estrone with low-normal testosterone and low androstendiol glucurunide. Testosterone injections (50mg once monthly for six months) were given that resulted in significant reduction in his gynecomastia. Molecular analysis revealed a previously unreported homozygous variant in exon eight of the HSD17B3 gene (NM_000197.1:c.576G>A.Trp192*). This variant creates a premature stop codon, which is very likely to result in a truncated protein or loss of protein production. This is the first report in the medical literature of this novel HSD17B3 gene mutation. A literature review was conducted to identify the previous studies related to this disorder.
Keywords: 17-β-Hydroxysteriod Dehydrogenase Type 3 Deficiency; Ambiguous Genitalia; Delta-4-Androstenedione; Disorder of Sex Development, 46,XY; Estrone; HSD17B3 gene; Testosterone.
Figures
Similar articles
-
Disorder of Sex Development Due to 17-Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Report and Review of 70 Different HSD17B3 Mutations Reported in 239 Patients.Int J Mol Sci. 2022 Sep 2;23(17):10026. doi: 10.3390/ijms231710026. Int J Mol Sci. 2022. PMID: 36077423 Free PMC article. Review.
-
46,XY Sex Development Defect due to a Novel Homozygous (Splice Site) c.673_1G>C Variation in the HSD17B3 Gene: Case Report.J Clin Res Pediatr Endocrinol. 2022 Jun 7;14(2):233-238. doi: 10.4274/jcrpe.galenos.2020.2020.0249. Epub 2021 Jan 4. J Clin Res Pediatr Endocrinol. 2022. PMID: 33389920 Free PMC article.
-
46,XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency.J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):79-85. doi: 10.1016/j.jsbmb.2016.05.002. Epub 2016 May 6. J Steroid Biochem Mol Biol. 2017. PMID: 27163392 Review.
-
A novel nonsense mutation in HSD17B3 gene in a Tunisian patient with sexual ambiguity.J Sex Med. 2013 Oct;10(10):2586-9. doi: 10.1111/j.1743-6109.2012.02763.x. Epub 2012 May 17. J Sex Med. 2013. PMID: 22594312
-
46,XY Disorder of Sex Development due to 17-Beta Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Infant of Greek Origin.J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):74-78. doi: 10.4274/jcrpe.4829. Epub 2017 Jul 24. J Clin Res Pediatr Endocrinol. 2018. PMID: 28739554 Free PMC article.
Cited by
-
Pre-puberty cannabichromene exposure modulates reproductive function via alteration of spermatogenesis, steroidogenesis, and eNOS pathway metabolites.Toxicol Rep. 2023 Jun 3;10:690-705. doi: 10.1016/j.toxrep.2023.06.001. eCollection 2023. Toxicol Rep. 2023. PMID: 37396845 Free PMC article.
-
Guidance for shared decision-making regarding orchiectomy in individuals with differences of sex development due to 17-β-hydroxysteroid dehydrogenase type 3 deficiency.Front Pediatr. 2025 Feb 20;13:1549400. doi: 10.3389/fped.2025.1549400. eCollection 2025. Front Pediatr. 2025. PMID: 40051913 Free PMC article. Review.
-
Disorder of Sex Development Due to 17-Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Report and Review of 70 Different HSD17B3 Mutations Reported in 239 Patients.Int J Mol Sci. 2022 Sep 2;23(17):10026. doi: 10.3390/ijms231710026. Int J Mol Sci. 2022. PMID: 36077423 Free PMC article. Review.
References
-
- Mula-Abed WA, Pambinezhuth FB, Al-Kindi MK, Al-Busaidi NB, Al-Muslahi HN, Al-Lamki MA. Congenital adrenal hyperplasia due to 17-alpha-hydoxylase/17,20-lyase deficiency presenting with hypertension and pseudohermaphroditism: First case report from Oman. Oman Med J 2014. Jan;29(1):55-59. 10.5001/omj.2014.12 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources